Ramesh Rengan, MD, PhD

Several reports have described how the use of radiation therapy in patients on immunotherapy can trigger immunogenic cell death.

In this video, Ramesh Rengan, MD, PhD, of the University of Washington in Seattle, highlights research aiming to optimize this combination of radiation therapy and immunotherapy, and discusses unwanted immune responses from radiotherapy and the challenge of utilizing this combination in patients with brain metastases.

Rengan gave a presentation on this topic at the 2017 Multidisciplinary Thoracic Cancers Symposium.

Videos

This video examines how the use of radiation therapy in patients on immunotherapy can trigger immunogenic cell death, and reviews some of the challenges related to unwanted immune responses from radiotherapy.

Ramesh Rengan, MD, PhD

Articles

Optimizing Radiotherapy With Immunotherapy in Lung Cancer Treatment